1. Home
  2. IOVA vs HLIT Comparison

IOVA vs HLIT Comparison

Compare IOVA & HLIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IOVA
  • HLIT
  • Stock Information
  • Founded
  • IOVA 2007
  • HLIT 1988
  • Country
  • IOVA United States
  • HLIT United States
  • Employees
  • IOVA N/A
  • HLIT N/A
  • Industry
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • HLIT Radio And Television Broadcasting And Communications Equipment
  • Sector
  • IOVA Health Care
  • HLIT Technology
  • Exchange
  • IOVA Nasdaq
  • HLIT Nasdaq
  • Market Cap
  • IOVA 975.1M
  • HLIT 1.2B
  • IPO Year
  • IOVA N/A
  • HLIT 1995
  • Fundamental
  • Price
  • IOVA $2.17
  • HLIT $10.35
  • Analyst Decision
  • IOVA Buy
  • HLIT Buy
  • Analyst Count
  • IOVA 11
  • HLIT 6
  • Target Price
  • IOVA $11.90
  • HLIT $12.10
  • AVG Volume (30 Days)
  • IOVA 9.8M
  • HLIT 771.2K
  • Earning Date
  • IOVA 11-06-2025
  • HLIT 10-27-2025
  • Dividend Yield
  • IOVA N/A
  • HLIT N/A
  • EPS Growth
  • IOVA N/A
  • HLIT 16.91
  • EPS
  • IOVA N/A
  • HLIT 0.58
  • Revenue
  • IOVA $241,525,000.00
  • HLIT $689,084,000.00
  • Revenue This Year
  • IOVA $68.14
  • HLIT N/A
  • Revenue Next Year
  • IOVA $56.64
  • HLIT $25.21
  • P/E Ratio
  • IOVA N/A
  • HLIT $18.32
  • Revenue Growth
  • IOVA 636.99
  • HLIT 24.14
  • 52 Week Low
  • IOVA $1.64
  • HLIT $7.80
  • 52 Week High
  • IOVA $12.51
  • HLIT $15.46
  • Technical
  • Relative Strength Index (RSI)
  • IOVA 46.63
  • HLIT 57.48
  • Support Level
  • IOVA $1.97
  • HLIT $9.74
  • Resistance Level
  • IOVA $2.38
  • HLIT $10.84
  • Average True Range (ATR)
  • IOVA 0.13
  • HLIT 0.29
  • MACD
  • IOVA 0.02
  • HLIT 0.01
  • Stochastic Oscillator
  • IOVA 48.78
  • HLIT 52.73

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

About HLIT Harmonic Inc.

Harmonic Inc engaged in broadband access solutions that enable broadband operators to more efficiently and effectively deploy high-speed internet for data, voice, and video services for their customers and versatile and high-performance video delivery software, products, system solutions and services that enable its customers to efficiently create, prepare, store, playout and deliver a full range of high-quality broadcast and streaming video services to consumer devices, including televisions, personal computers, laptops, tablets, and smartphones. It has two segments, Broadband which provides broadband access solutions and related services, and Others; and Video business provides video processing and production and playout solutions and services, and Others.

Share on Social Networks: